Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

NCT07638007 · clinicaltrials.gov ↗

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Disease/Condition Name Cancer-related Cognitive Dysfunction
Chronic Lymphocytic Leukemia (CLL)
Chronic Myeloid Leukemia, BCR-ABL1 Positive

Sponsor

University of Rochester NCORP Research Base

Collaborators

[object Object]